The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy

Table 3 Multivariate analysis for potential prognostic factors

	Loco-regional PFS			Distant PFS			Global PFS			Overall Survival
Characteristics	OR	95% CI	P-value	OR	95% CI	P-value	OR	95% CI	P-value	OR	95% CI	P-value
Gender	0,41	0,03–4,94	0,4804	1,16	0,15–8,71	0,8880	0,80	0,09–6,83	0,8367	4,31	0,56–32,84	0,1591
Age	1,02	0,90–1,15	0,7026	0,92	0,83–1,02	0,1201	0,88	0,78–0,99	0,0413	1,04	0,93–1,15	0,4658
Baseline SUL_peak of T				0,87	0,75–0,99	0,0489
Baseline SUL_peak of N	1,16	0,97–1,38	0,0984
Early metabolic response	0,14	0,02–0,82	0,0292	0,15	0,03–0,71	0,0171	0,05	0,00–0,41	0,0059	0,24	0,05–1,06	0,0608
Surgery	0,14	0,02–0,91	0,0399				0,04	0,00–0,44	0,0093	0,23	0,03–1,39	0,1093

SUL _peak standardized uptake value corrected for lean body mass, PFS progression free survival, OR Odds ratio, CI confidence interval, T primary tumour, N lymph-node

ISSN: 1748-717X